Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:CHB

Global X China Biotech Innovation ETF (CHB) Price, Holdings, & News

About Global X China Biotech Innovation ETF (NASDAQ:CHB)

Key Stats

Today's Range
$6.64
$6.64
50-Day Range
$6.64
$6.67
52-Week Range
$6.63
$10.07
Volume
N/A
Average Volume
712 shs
Market Capitalization
$1.39 million
Assets Under Management
$1.41 million
Dividend Yield
0.45%
Net Expense Ratio
0.67%
Aggregate Rating
Buy

ETF Overview

The Global X China Biotech Innovation ETF (CHB) is an exchange-traded fund that is based on the Solactive China Biotech Innovation index. The fund tracks a market-cap weighted index of Chinese companies that are involved in the biotechnology industry. CHB was launched on Sep 22, 2020 and is managed by Global X.

Global X China Biotech Innovation ETF Expenses

TypeCHBTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.65%0.57%0.55%0.49%0.52%
Other Expenses0.02%0.57%0.49%0.42%0.54%
Total Expense0.67%0.73%0.70%0.63%0.71%
Fee Waiver0.00%-0.75%-0.52%-0.34%-0.58%
Net Expense0.67%0.59%0.61%0.56%0.59%
Receive CHB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X China Biotech Innovation ETF and its competitors with MarketBeat's FREE daily newsletter.

CHB ETF News Headlines

The panic button has already been pressed
If you missed it, my emergency election broadcast is now available - but will be removed on Monday at midnight.
This Chinese Biotech Stock Just Fell 24%
CHIE ETF Stock Price History
See More Headlines

Fund Details

Issuer
Global X
Fund Name
Global X China Biotech Innovation ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:CHB
Inception Date
9/22/2020
Fund Manager
Chang Kim, Nam To, Wayne Xie, Kimberly Chan
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Solactive China Biotech Innovation Index
Category
Strategy
Focus
Theme
Development Level
Emerging Markets
Region
Asia-Pacific
Number of Holdings
2

Fund Statistics

Assets Under Management
$1.41 million
Average Daily Volume
$0.00
Discount/Premium
-0.07%

Administrator, Advisor and Custodian

Administrator
Global X Management Company LLC
Advisor
Global X Management Company LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
SEI Investments Distribution Co.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
Susquehanna

Options

Optionable
N/A
Short Interest
8,800 shs

Miscellaneous

Beta
0.29
Creation Unit
50,000
Creation Fee
$600.00
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Top 10 CHB Holdings

  • WuXi Biologics (Cayman) Inc
    Holding Weight: 8.87%
  • Changchun High and New Technology Industry Group Inc Class A
    Holding Weight: 7.91%
  • Chongqing Zhifei Biological Products Co Ltd Class A
    Holding Weight: 7.71%
  • Walvax Biotechnology Co Ltd Class A
    Holding Weight: 7.60%
  • CSPC Pharmaceutical Group Ltd
    Holding Weight: 7.18%
  • Shanghai RAAS Blood Products Co Ltd Class A
    Holding Weight: 4.94%
  • Beijing Tiantan Biological Products Corp Ltd Class A
    Holding Weight: 4.76%
  • Hualan Biological Engineering Inc Class A
    Holding Weight: 4.58%
  • Sichuan Kelun Pharmaceutical Co Ltd Class A
    Holding Weight: 4.33%
  • Zai Lab (NASDAQ:ZLAB)
    Holding Weight: 4.11%

This page (NASDAQ:CHB) was last updated on 10/5/2024 by MarketBeat.com Staff
From Our Partners